These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8423115)

  • 1. Toward quality assurance in QALY calculations.
    Nord E
    Int J Technol Assess Health Care; 1993; 9(1):37-45. PubMed ID: 8423115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life years.
    Bravo Vergel Y; Sculpher M
    Pract Neurol; 2008 Jun; 8(3):175-82. PubMed ID: 18502950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The QALY--a measure of social value rather than individual utility?
    Nord E
    Health Econ; 1994; 3(2):89-93. PubMed ID: 8044215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health related utility measurement: an introduction.
    Bakker C; van der Linden S
    J Rheumatol; 1995 Jun; 22(6):1197-9. PubMed ID: 7674256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A guide to the critical reflection of health services research studies].
    Donner-Banzhoff N; Schrappe M; Lelgemann M
    Z Arztl Fortbild Qualitatssich; 2007; 101(7):463-71. PubMed ID: 18183867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 8. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
    Gupta OP; Brown GC; Brown MM
    Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.
    Chuback J; Yarascavitch B; Yarascavitch A; Kaur MN; Martin S; Thoma A
    Burns; 2015 Nov; 41(7):1524-31. PubMed ID: 26068209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ranking properties of healthy-years equivalents and quality-adjusted life-years under certainty and uncertainty.
    Johannesson M
    Int J Technol Assess Health Care; 1995; 11(1):40-8. PubMed ID: 7706013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime QALY prioritarianism in priority setting.
    Ottersen T
    J Med Ethics; 2013 Mar; 39(3):175-80. PubMed ID: 23204320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing SF-6D Health States Using a Discrete Choice Experiment.
    Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
    Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cost per year of life gained: trends and internal contradictions].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2467-70. PubMed ID: 17137090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
    Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
    Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of reporting in published cost-utility analyses, 1976-1997.
    Neumann PJ; Stone PW; Chapman RH; Sandberg EA; Bell CM
    Ann Intern Med; 2000 Jun; 132(12):964-72. PubMed ID: 10858180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK.
    Tavakoli M; Malek M
    J Neurol Sci; 2001 Oct; 191(1-2):95-102. PubMed ID: 11676998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quality of QALYs (quality-adjusted-life-years): do QALYs measure what they at least intend to measure?
    Gafni A
    Health Policy; 1989 Oct; 13(1):81-3. PubMed ID: 10296157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosing conflicts of interest in German publications concerning health services research.
    Schneider N; Lingner H; Schwartz FW
    BMC Health Serv Res; 2007 Jun; 7():78. PubMed ID: 17543111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.
    Yang SC; Lai WW; Chang HY; Su WC; Chen HH; Wang JD
    Lung Cancer; 2014 Oct; 86(1):96-101. PubMed ID: 25178685
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.